...
首页> 外文期刊>Journal of Korean medical science. >A Rare Case of Essential Thrombocythemia with Coexisting JAK2 and MPL Driver Mutations
【24h】

A Rare Case of Essential Thrombocythemia with Coexisting JAK2 and MPL Driver Mutations

机译:A Rare Case of Essential Thrombocythemia with Coexisting JAK2 and MPL Driver Mutations

获取原文
获取原文并翻译 | 示例
           

摘要

Philadelphia-negative (Ph-) classical myeloproliferative neoplasms (MPNs) include polycythemia vera, essential thrombocythemia (ET), and primary myelofibrosis. Somatic driver mutations in the JAK2, CALR, and MPL genes serve as major diagnostic criteria of the Ph- MPNs and these mutations occur in a mutually exclusive manner. In this report, we describe the first case of ET harboring double mutations in JAK2 V617F and MPL. For MPL, the patient had multiple clones of MPL mutations: c.1543_1546delinsAGGG (p.Trp515_Gln516delinsArgGlu) and c.1546CG (p.Gln516Glu). The JAK2 V617F allele burden in our patient is very low (4) compared to the relatively high (17-78) allele frequency of MPL mutations. The low JAK2 mutant burden might be explained by preexisting clonal hematopoiesis before overt signs of MPNs, followed by the acquisition of a second oncogenic mutation of CALR or MPL leading to the MPN phenotype. This highlights that screening for a second driver mutation should be considered in patients with a low JAK2 mutant burden by reporting a 57-year-old Korean man with ET.© 2020 The Korean Academy of Medical Sciences.

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号